Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 - Test2 - elhamkhani - TriplyDB

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

http://www.wikidata.org/entity/Q24651548

about

GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival SVD identifies transcript length distribution functions from DNA microarray data and reveals evolutionary forces globally affecting GBM metabolism Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme Mutational profiling of kinases in glioblastoma.Combing the hairball with BioFabric: a new approach for visualization of large networks A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature Epigenetic pathways and glioblastoma treatment A Balanced Look at the Implications of Genomic (and Other "Omics") Testing for Disease Diagnosis and Clinical Care VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells The bromodomain protein Brd4 insulates chromatin from DNA damage signalling Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas IDH1 and IDH2 mutations in gliomas NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas Ion channels in glioblastoma Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma Neural stem cells: brain building blocks and beyond Consensus on the role of human cytomegalovirus in glioblastoma Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases Recent advances in the molecular understanding of glioblastoma Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas Current status of biomarker research in neurology New perspectives in glioblastoma antiangiogenic therapy Cancer Stem Cell Hierarchy in Glioblastoma Multiforme Glioma Stem Cells: Signaling, Microenvironment, and Therapy Understanding Genotype-Phenotype Effects in Cancer via Network Approaches An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts Advances in the treatment of newly diagnosed glioblastoma Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

P2860

Q21090956-E2E68725-86D8-4A4C-818E-5CDA9A66D25B Q21132447-47814A6C-96E1-4507-A0D7-02D7559D67FA Q21135142-2D371087-0F26-4590-8F89-6763FC9EF374 Q21183973-891D932E-6C2E-4F8D-B447-F5A2E0571038 Q21261249-C69D63D8-B0C7-40FB-91EA-861DE6690A38 Q21284319-E7C7B452-0B5B-41BE-9B0F-379396EF8C5E Q21560781-9019FC49-852D-486C-AEA1-B8DE30669932 Q24273294-33F86A52-671B-4241-8C8B-CF9868C94563 Q24273314-B9243061-D2F0-48FD-B8F4-BD1B81C5613A Q24293027-674DE693-ED7A-4E40-A4EE-5BBC07CE2FDB Q24293124-478A3298-3C1C-4B61-9CFD-7F68EE1AEA8D Q24294320-A2970FC7-49A8-4E0F-B458-571093807A47 Q24299628-CAC5243E-32E5-4F47-BF55-897499F3FF21 Q24307815-8239BD6B-90C8-4C91-9122-EC41E88288A6 Q24561928-83A73638-D214-425B-AE66-28BF29B78C80 Q24604657-14A19E09-14BB-4C87-B704-5FCC2B9FAC48 Q24604724-D1EEE57F-B58A-42AA-94C0-5263354397BA Q24610836-F01CE6DC-4F3E-4976-BA36-281B7D893CE0 Q24612429-9ADEDE73-B217-468F-8694-990521020102 Q24629145-C7342BAA-A727-4AA2-B7C6-CB60E1DFD3E8 Q24631889-3D56176E-AA46-49CA-89E4-7BEEC8B838D7 Q24632103-586A47AE-E807-4121-938C-7DC2ED536A95 Q24632760-2377392D-D2A6-45EE-BD1B-E3E1F492AD9F Q24632791-6DB39D4A-1011-42BA-8DC7-4BC6503E4615 Q24632807-C8F3967E-98DA-4A9C-B2F3-8AB5DB767D26 Q24632928-5AFB3C6B-BC18-43E9-AF17-08073DE39C14 Q24810414-72A10D39-94F5-40DA-96CF-16188EBAF3CE Q26744505-BDF25844-9E58-4E4E-97E0-B33AD385B465 Q26746028-04E2BA6E-D78B-444F-93BE-622B744EFF01 Q26752312-5A758DD0-4A61-4549-9056-5494D130F15F Q26765854-40551122-EA3A-41F9-A3C3-D32509195608 Q26766543-4C605246-F6FA-4FDD-9DCC-A0E29C96828A Q26772895-F3064EB1-3DC8-4ABD-A103-D5F9E0F51FCA Q26773514-958A52E3-269B-4314-81F2-C68A8C7D2089 Q26774502-A61101B4-CD2D-474D-B916-D1B331226015 Q26774717-94D3AF9B-7248-43FE-BA5E-CD7586FBEE08 Q26781836-52C71677-62FF-45D0-90C5-9D9EE52DDCF9 Q26795601-3375975A-FD2F-4E3D-BC94-99EE9B55701F Q26796590-0346A6FF-64A9-4FBD-A161-E8B7DC71B18D Q26797238-C42DE248-BB6A-4CB2-B03F-FBF5B70A7236

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

http://www.wikidata.org/entity/Q24651548

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@ast

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@en

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@nl

type

label

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@ast

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@en

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@nl

prefLabel

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@ast

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@en

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@nl

P1433

Q24651548-323263A3-1BE4-40B4-B50D-FE13A7DB9E45

P1476

Q24651548-6C3060AA-ECFC-415B-A3C5-775458E9E06F

P2093

Q24651548-03C11432-27B4-4891-9CC2-26D90A8C2588

Q24651548-057D9D0A-62AB-48CE-B892-BEC21C13336D

Q24651548-16968F66-D36A-4AF2-8D07-CC4FEFA6CFBA

Q24651548-3624D4A5-0FC9-4C77-B67F-043D80681BBB

Q24651548-36570EDB-83BE-4DD6-963D-198F2C90ED0D

Q24651548-4365837D-8F48-4F42-8A20-34229C5D81D6

Q24651548-451426E0-FE15-4A36-A6FE-9ABBD3D2B981

Q24651548-5DE78026-F1F6-4B8D-BF41-40346DA45034

Q24651548-684C8056-D172-4C94-A766-8230496228CB

Q24651548-75960A40-66E6-4E15-A7F8-40AF1385AB07

P2860

Q24651548-0F2BF533-0363-430F-A35C-421A0B273557

Q24651548-111884D8-3832-4409-91A3-3B672E07BA11

Q24651548-17CE6ED7-1C4D-4B0A-9606-3F5DBF7FD601

Q24651548-305D10DC-6210-4425-809B-7B73E804EDF4

Q24651548-35DECAC6-D98D-4775-B9E1-80003C62234A

Q24651548-39819B1A-6A17-421B-9825-C086C14FAF41

Q24651548-3B7DAFE4-820D-4D25-A11A-F5CDC0A20217

Q24651548-4A3EAF62-AC5F-4CAC-BC51-292075735AAF

Q24651548-4C2728E2-456B-4E2E-AEC0-78674CEC1EE9

Q24651548-53482BB8-F1CF-423B-8DB5-A21D524A3E0D

P304

Q24651548-E38B4943-611F-4F8D-8D75-C4DB14A172FA

P31

Q24651548-622E705C-6F2E-451A-A466-A389BE50929C

P3181

Q24651548-C963D85F-B19C-4190-B3CE-2F1BA1B0AD50

P356

Q24651548-74B78020-89D3-4912-B7E7-30F52052ABF3

P407

Q24651548-7D584F99-38BA-4BE0-877A-7BE2FA697D6E

P433

Q24651548-05E95288-2CA5-4448-B1A4-C98ABBADAF58

P478

Q24651548-ED2B761A-3449-4E7F-9BA9-DF106489E205

P50

Q24651548-274BEC21-5660-4249-AA64-CE5789EDBD94

Q24651548-27C1A0A5-AFAC-433E-A016-544817C22D12

Q24651548-27F12A9F-A422-49E1-AB8C-2DD11C6C972D

Q24651548-8018036E-8C16-4019-8518-A09C393986B7

Q24651548-9E3E81E9-3CE3-49B4-8C98-2724A8CFB8ED

Q24651548-A51D06C1-0EEA-45B5-81C8-5A944C94B344

Q24651548-A5AFAF5F-5E6C-4E01-99B3-81B78EE0EBA9

Q24651548-BAAD60FD-35EA-48FA-8802-98B045D4FC92

P577

Q24651548-9F70BB6E-4D39-4827-9007-DA91EF5D8678

P5875

Q24651548-16877ACF-86B9-42D1-9B88-23ECA5D32B6E

P698

Q24651548-233BAC59-62D3-40E0-BA40-EE711933423C

P921

Q24651548-6958D529-4FB1-4DC4-B747-FB231C423E8A

P932

Q24651548-5BDBAB67-23E6-404D-B1C0-A906AEF76E1B

P3181

P356

J.CCR.2009.12.020

P1433

P1476

Integrated genomic analysis id ...... in PDGFRA, IDH1, EGFR, and NF1

@en

P2093

Ari Kahn

http://www.w3.org/2001/XMLSchema#string

Barbara A Weir

http://www.w3.org/2001/XMLSchema#string

C David James

http://www.w3.org/2001/XMLSchema#string

C Ryan Miller

http://www.w3.org/2001/XMLSchema#string

D Neil Hayes

http://www.w3.org/2001/XMLSchema#string

Elizabeth Purdom

http://www.w3.org/2001/XMLSchema#string

Gabriele Alexe

http://www.w3.org/2001/XMLSchema#string

Heidi S Feiler

http://www.w3.org/2001/XMLSchema#string

J Graeme Hodgson

http://www.w3.org/2001/XMLSchema#string

Jann N Sarkaria

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

Significance analysis of microarrays applied to the ionizing radiation response

IDH1 and IDH2 mutations in gliomas

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

DAVID: Database for Annotation, Visualization, and Integrated Discovery

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Epithelial-mesenchymal transitions in tumour progression

Summaries of Affymetrix GeneChip probe level data

Neural stem cells and the origin of gliomas

P304

98-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

142548

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CCR.2009.12.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Jill P. Mesirov

Cameron Brennan

Charles M. Perou

Matthew Meyerson

P577

2010-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41404206

http://www.w3.org/2001/XMLSchema#string

P698

20129251

http://www.w3.org/2001/XMLSchema#string

P921

P932

2818769

http://www.w3.org/2001/XMLSchema#string